Student Scientific Group of Internal Medicine and Allergology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Clinical Department of Internal Medicine, Pneumology and Allergology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Int J Mol Sci. 2024 Jun 28;25(13):7092. doi: 10.3390/ijms25137092.
Pulmonary alveolar proteinosis (PAP) is an ultra-rare disease caused by impaired pulmonary surfactant clearance due to the dysfunction of alveolar macrophages or their signaling pathways. PAP is categorized into autoimmune, congenital, and secondary PAP, with autoimmune PAP being the most prevalent. This article aims to present a comprehensive review of PAP classification, pathogenesis, clinical presentation, diagnostics, and treatment. The literature search was conducted using the PubMed database and a total of 67 articles were selected. The PAP diagnosis is usually based on clinical symptoms, radiological imaging, and bronchoalveolar lavage, with additional GM-CSF antibody tests. The gold standard for PAP treatment is whole-lung lavage. This review presents a summary of the most recent findings concerning pulmonary alveolar proteinosis, pointing out specific features that require further investigation.
肺泡蛋白沉积症(PAP)是一种超罕见疾病,由肺泡巨噬细胞或其信号通路功能障碍导致肺表面活性物质清除受损引起。PAP 分为自身免疫性、先天性和继发性 PAP,其中自身免疫性 PAP 最为常见。本文旨在全面综述 PAP 的分类、发病机制、临床表现、诊断和治疗。通过 PubMed 数据库进行文献检索,共选择了 67 篇文章。PAP 的诊断通常基于临床症状、影像学和支气管肺泡灌洗,以及 GM-CSF 抗体测试。PAP 治疗的金标准是全肺灌洗。本文综述了有关肺泡蛋白沉积症的最新研究结果,指出了需要进一步研究的特定特征。